Zach Jonasson, PhD
Principal, Seaflower Ventures

Dr. Jonasson is a Senior Principal at Seaflower Ventures, where he focuses on early-stage investments in drug development and healthcare service companies. He currently represents Seaflower as a board observer at Serenex Inc. and previously served as board observer at eMed Technologies and as director of MetaWorks. Previously, Zach was a consultant at Risk Capital Management Partners (RCM) and held a Research Associateship at the Board of Governors of the Federal Reserve. Dr. Jonasson completed a Ph.D. in Neuroscience at Harvard as a Sackler Scholar. He also holds an A.M. in Statistics from Harvard and a B.S. from Georgetown, where he was a Rhodes Scholarship Finalist. You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near '' at line 1